pipette
ENEnglish

The MASLD-causing E167K variant of TM6SF2 is degraded by the ubiquitin ligase RNF5

E. Heidary Arash, H. Pan, H. Willenbring

PreprintUso en el mundo real

En palabras de los autores

The TM6SF2 E167K loss-of-function variant is one of the most penetrant genetic risk factors for metabolic dysfunction-associated steatotic liver disease (MASLD), including progression to cirrhosis and hepatocellular carcinoma. Here we show that TM6SF2 E167K is recognized and degraded by the ER-associated degradation pathway, and identify RNF5 as the ubiquitin ligase tagging TM6SF2 E167K, providing a rational target for MASLD therapy.

Resultado principalEl resumen no menciona limitaciones.

Apareció: sábado, 24 de octubre. bioRxiv. Preprint, todavía sin revisión por pares.

DOI: 10.64898/2026.10.21.760790